De Luca G - Search Results

1

Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets.

Silverio A, Cancro FP, Esposito L, Bellino M, D'Elia D, Verdoia M, Vassallo MG, Ciccarelli M, Vecchione C, Galasso G, De Luca G. Silverio A, et al. Among authors: de luca g. J Clin Med. 2023 Mar 10;12(6):2161. doi: 10.3390/jcm12062161. J Clin Med. 2023. PMID: 36983163 Free PMC article. Review.

2

Rheolytic thrombectomy during percutaneous coronary intervention improves long-term outcome in high-risk patients with acute myocardial infarction.

De Rosa S, Cirillo P, De Luca G, Galasso G, Esposito G, Leosco D, Piscione F, Chiariello M. De Rosa S, et al. Among authors: de luca g. J Interv Cardiol. 2007 Aug;20(4):292-8. doi: 10.1111/j.1540-8183.2007.00271.x. J Interv Cardiol. 2007. PMID: 17680859 Free article.

3

Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: A meta-analyis of randomised trials.

De Luca G, Cassetti E, Verdoia M, Marino P. De Luca G, et al. Thromb Haemost. 2009 Sep;102(3):428-36. doi: 10.1160/TH09-05-0287. Thromb Haemost. 2009. PMID: 19718462 Review.

4

Thrombectomy during primary angioplasty: methods, devices, and clinical trial data.

De Luca G, Verdoia M, Cassetti E. De Luca G, et al. Curr Cardiol Rep. 2010 Sep;12(5):422-8. doi: 10.1007/s11886-010-0133-6. Curr Cardiol Rep. 2010. PMID: 20645031 Review.

5

High fibrinogen level is an independent predictor of presence and extent of coronary artery disease among Italian population.

De Luca G, Verdoia M, Cassetti E, Schaffer A, Cavallino C, Bolzani V, Marino P; Novara Atherosclerosis Study Group (NAS). De Luca G, et al. J Thromb Thrombolysis. 2011 May;31(4):458-63. doi: 10.1007/s11239-010-0531-z. J Thromb Thrombolysis. 2011. PMID: 21080031 Clinical Trial.

6

Evaluation and management of special subgroups after primary percutaneous coronary intervention.

De Luca L, Tomai F, Verdoia M, De Luca G. De Luca L, et al. Among authors: de luca g. Am Heart J. 2010 Dec;160(6 Suppl):S22-7. doi: 10.1016/j.ahj.2010.10.012. Am Heart J. 2010. PMID: 21147288

7

Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy.

De Luca G, Navarese EP, Cassetti E, Verdoia M, Suryapranata H. De Luca G, et al. Am J Cardiol. 2011 Jan 15;107(2):198-203. doi: 10.1016/j.amjcard.2010.08.063. Am J Cardiol. 2011. PMID: 21211597 Review.

8

Ischaemic and bleeding complications with new, compared to standard, ADP-antagonist regimens in acute coronary syndromes: a meta-analysis of randomized trials.

Navarese EP, Verdoia M, Schaffer A, Suriano P, Kozinski M, Castriota F, De Servi S, Kubica J, De Luca G. Navarese EP, et al. Among authors: de luca g, de servi s. QJM. 2011 Jul;104(7):561-9. doi: 10.1093/qjmed/hcr069. Epub 2011 May 13. QJM. 2011. PMID: 21572108 Review.

9

Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience.

De Luca G, Verdoia M, Binda G, Schaffer A, Suryapranata H, Marino P. De Luca G, et al. Int J Cardiol. 2013 Jul 31;167(2):561-3. doi: 10.1016/j.ijcard.2012.01.063. Epub 2012 Feb 24. Int J Cardiol. 2013. PMID: 22365313

10

Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials.

De Luca G, Verdoia M, Suryapranata H. De Luca G, et al. Atherosclerosis. 2012 Jun;222(2):426-33. doi: 10.1016/j.atherosclerosis.2012.02.041. Epub 2012 Mar 7. Atherosclerosis. 2012. PMID: 22483166 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,657 results

Search Page

Filters